FilingsTodayColgate Palmolive
At a glance
Colgate Palmolive reported 2025 revenue of $20.38B, up 1.4% from $20.1B in 2024. Over 4 years since 2021 ($17.42B), that is growth of about 4% a year. Operating margin was 16.2%, down from 19.1% in 2021. 2025 was the highest revenue year in this period.
In the last 12 months 8 insiders reported 0 open-market purchases and 13 sales ($57.1M). None of the sales were flagged as 10b5-1 plan trades. The largest was a sale of $29.7M by Chairman, President & CEO Noel R. Wallace on Aug 6, 2026.
Colgate Palmolive filed 10 current reports (Form 8-K) in the last 12 months, most often for results of operations (5), exit or restructuring costs (2), officer or director change (2) and other events (2). The latest officer or director change was reported on Apr 9, 2026.
3 of the 20 investors tracked here held Colgate Palmolive at the last quarter end, worth $306.6M combined. It is the largest weight for National Pension Service (Korea) (0.1% of its portfolio), followed by Renaissance Technologies (0.1%). Added: National Pension Service (Korea). Reduced: Renaissance Technologies and Bridgewater Associates.
Annual results
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | $2.17B | $1.78B | $2.3B | $2.89B | $2.13B |
| Diluted EPS | $2.55 | $2.13 | $2.77 | $3.51 | $2.63 |
| Dividend per share | $1.79 | $1.86 | $1.91 | $2.48 | $2.08 |
Fiscal year ends Dec 31 · incorporated in DE
Tracked investors holding (13F)
Weight is the share of each investor's portfolio, as of the quarter end.
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined